UiPath reported robust third-quarter results for fiscal 2026, with annualized renewal run rates (ARR) rising 11% year-over-year and total revenue climbing 16% from the comparable period last year. The company’s gross margin held steady at approximately 83%, underscoring operational leverage as sales volumes expanded. Non-GAAP operating income improved by 25% sequentially, reflecting disciplined expense management against continued investment in research and development for its agentic AI roadmap.

As of the end of October, UiPath serves nearly 10,900 enterprise customers, including more than 2,500 organizations that each contribute over $100,000 in ARR. Notable additions during the quarter included global deployments within Alphabet’s marketing division and a multi-year renewal with a Fortune 500 financial institution. The company’s Automation Cloud platform now supports over 1.2 million attended and unattended bots in production, up 30% year-over-year, highlighting accelerating adoption of agentic automation across finance, healthcare and telecommunications verticals.

Recent disclosures show CEO Daniel Dines executed three separate sales of 45,000 shares each between January 9 and January 14, reducing his stake by approximately 0.16%. Total proceeds from those transactions amounted to just over $2.2 million. While some analysts cite these filings as a potential near-term headwind, consensus ratings remain largely unchanged, with an average price target implying mid-teens upside. Institutional holdings account for roughly 62.5% of outstanding shares, and unusual call-option volume spiked by over 50% on select trading days, signaling sustained speculative interest in the automation specialist.